GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Frequency Exchange Corp (TSXV:FREQ) » Definitions » EBITDA Margin %

Frequency Exchange (TSXV:FREQ) EBITDA Margin % : -211.32% (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Frequency Exchange EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Frequency Exchange's EBITDA for the three months ended in Sep. 2023 was C$-0.34 Mil. Frequency Exchange's Revenue for the three months ended in Sep. 2023 was C$0.16 Mil. Therefore, Frequency Exchange's EBITDA margin for the quarter that ended in Sep. 2023 was -211.32%.


Frequency Exchange EBITDA Margin % Historical Data

The historical data trend for Frequency Exchange's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frequency Exchange EBITDA Margin % Chart

Frequency Exchange Annual Data
Trend Oct20 Oct21 Dec22
EBITDA Margin %
- - -676.25

Frequency Exchange Quarterly Data
Oct20 Jan21 Oct21 Jan22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -347.97 -297.63 -170.97 -158.03 -211.32

Competitive Comparison of Frequency Exchange's EBITDA Margin %

For the Medical Devices subindustry, Frequency Exchange's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Frequency Exchange's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Frequency Exchange's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Frequency Exchange's EBITDA Margin % falls into.



Frequency Exchange EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Frequency Exchange's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-4.727/0.699
=-676.25 %

Frequency Exchange's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-0.336/0.159
=-211.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Frequency Exchange  (TSXV:FREQ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Frequency Exchange EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Frequency Exchange's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Frequency Exchange (TSXV:FREQ) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, Suite 2050, PO Box 11121, Vancouver, BC, CAN, V6E 3P3
Frequency Exchange Corp is focused on the development and global commercialization of a wearable Frequency Delivery System providing specialized programs designed for health and wellness as well as performance enhancement.
Executives
Stephen Davis 10% Security Holder, Director, Senior Officer